Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.

他人的希望(我们的组织有助于增强研究和科学):匹兹堡大学乳腺癌快速尸检项目的研究成果

阅读:11
作者:Chang Alexander Chih-Chieh, Balic Marija, Bartholow Tanner, Bhargava Rohit, Brown Daniel D, Brown Lauren, Brufsky Adam, Cao Ye, Carleton Neil, Clark Amanda M, Cody Morgan, Ding Kai, Deible Christopher, Elangovan Ashuvinee, Foldi Julia, Geisler Daniel, Hodgdon Christine, Howard Naomi, Li Zheqi, Liu Jie Bin, Lopez-Nunez Oscar, Mary Dixcy Jaba Sheeba John, McGinn Olivia, Miller Lori, Mori Kanako, Pecar Geoffrey, Priedigkeit Nolan, Puhalla Shannon, Rosenzweig Margaret Q, Roy Partha, Savariau Laura, Walker Stephanie, Waltermire Hunter, Wedn Abdalla M, Wells Alan, Yates Megan E, Xavier Jennifer, Lee Adrian V, Oesterreich Steffi
Breast cancer affects 1/8 of women throughout their lifetimes, with over 90% of cancer deaths being caused by metastasis. However, metastasis poses unique challenges to research, as complex changes in the microenvironment in different metastatic sites and difficulty obtaining tissue for study hinder the ability to examine in depth the changes that occur during metastasis. Rapid autopsy programs thus fill a unique need in advancing metastasis research. Here, we describe our protocol and processes for establishing and improving the US-based Hope for OTHERS (Our Tissue Helping Enhance Research and Science) program for organ donation in metastatic breast cancer. As of August 2024, we consented 114 patients and performed 37 autopsies, from which we collected 551 unique metastatic frozen tumor samples, 1244 FFPE blocks, 90 longitudinal liquid biopsy samples and developed 14 patient-derived organoid and 8 patient-derived xenograft models. We report in-depth clinical and histopathological information and discuss extensive new research and novel findings in patient outcomes, metastatic phylogeny, and factors in successful living model development. Our results reveal key logistical and protocol improvements that are uniquely beneficial to certain programs based on identifiable features, such as working closely with patient advocates, methods to rescue RNA quality in cases where tissue quality may degrade due to time delays, as well as guidelines and future expansions of our program.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。